SCHEMBL23948675

SCHEMBL23948675

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2c3c(ccc2n2c5ccccc5nc42)[nH]c2ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.37
MAPT P10636 5/20 0.37
LMNA P02545 2/20 0.37
POLB P06746 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 6/20 0.36
ALDH1A1 P00352 5/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CAMKK1 Q8N5S9 2/20 0.32
CAMKK2 Q96RR4 2/20 0.32
CYP2D6 P10635 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948819 1.00 KDM4E (0.37) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL23948418 0.88 KDM4E (0.37) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL23948674 0.85 KDM4E (0.36) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL23948652 0.83 GABRP (0.35) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890205 0.81 KDM4E (0.49) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890180 0.81 KDM4E (0.49) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890199 0.81 KDM4E (0.49) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL16066271 0.81 KDM4E (0.44) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890605 0.81 KDM4E (0.43) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890404 0.80 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 KDM4E 2817/4885MAPT 1313/4885LMNA 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.